Scott Rocklage has a wealth of knowledge in the field of healthcare management. He has rendered his services in the industry for over three decades. His achievements in the industry include spearheading the approval of three US New Drug Application (Omniscan™, Telescan® and Cubicin® ) by FDA. He has also pushed for the clinical trials of multiple drug candidates.
Scott has held top management positions, including R&D positions at Cubist Pharmaceuticals, Nycomed Salutar and Catalyca. Presently, he chairs the board of Pulmatrix and Epirus, Kinestral, Rennovia, and Cidara. Previously, he chaired the board of Relypsa and Novira and served as the executive chairman of Miikana, Semprus and Ilypsa. Mr. Rocklage holds over 30 patents. He has has authored over 100 publications. Learn more about Scott Rocklage: http://chemistry.mit.edu/scott-rocklage-phd-2-and-his-wife-patty-are-celebrated-their-major-gift
The celebrated scientist initially attended the University of California, Berkeley where he graduated with his BS in Chemistry before enrolling at MIT. He joined 5AM Ventures as a Venture Partner in 2003. He assumed his current position in the following year. 5AM also invests in later stage life science companies and private equities.
They invest in biotechnology, health and wellness, as well as health care and research instruments. The company was founded by Andrew Schwab and John Diekman in 2002.
Through 5AM, Scott has invested in Achaogen and Novira Therapeutics. Speaking to ideamensch, Scott said that he collaborates with entrepreneurs from various fields of science to help them develop potential medicines to treat stubborn diseases. The shrewd entrepreneur is never afraid to take risks.
Scott Rocklage, PhD is an accomplished scientist and the managing partner at 5AM Ventures, a company that invests in early-stage life science companies. Scott’s career has been defined by giving back to the community by actively participating in various philanthropic activities. Rocklage, who attended MIT Department of Chemistry for his PhD studies, was recently celebrated for his generous contribution towards the renovation of the department’s nanochemistry and nanotechnology lab.
Scott and his wife, Patty Rocklage, were honored with a plaque displayed at the vestibule of the new lab. Tributes were also paid to the duo by the leaders of the department. Dr. Scott said that MIT established his career foundation. This way, he was obliged to give back as a token of appreciation.